Neurogenic bladder in patients with traumatic spinal cord injury: treatment and follow-up
| Autor: | Ebru Alemdaroğlu, Ayşenur Bardak, Ece Çınar, Bilge Yilmaz, N Catalbaş, Hakan Tunç, Yesim Akkoc, Yasin Demir, Murat Ersöz, Seçilay Güneş, Kurtuluş Köklü, Berrin Gündüz, Ridvan Alaca, Hale Karapolat, Haydar Gök, Necmettin Yildiz, I Turna, Belgin Erhan |
|---|---|
| Přispěvatelé: | Ege Üniversitesi |
| Jazyk: | angličtina |
| Rok vydání: | 2014 |
| Předmět: |
Questionnaires
Male intermittent catheterization spinal cord lesion retrospective study urologic and male genital diseases Cholinergic Antagonists Adolescent Adult Aged Cholinergic Antagonists/therapeutic use Cross-Sectional Studies Female Follow-Up Studies Humans Intermittent Urethral Catheterization Middle Aged Retrospective Studies Sex Factors Spinal Cord Injuries/drug therapy/*physiopathology/*rehabilitation Surveys and Questionnaires Treatment Outcome Urinary Bladder Neurogenic/drug therapy/*physiopathology/*rehabilitation Urinary Tract Infections/drug therapy/physiopathology Young Adult middle aged cholinergic receptor blocking agent bladder training indwelling catheter pathophysiology media_common fever solifenacin Urinary bladder adult medical specialist trospium chloride article neurogenic bladder clinical trial General Medicine condom catheter oxybutynin female genital diseases and pregnancy complications aged female medicine.anatomical_structure priority journal Neurology Urinary Tract Infections quadriplegia young adult disease severity Propiverine Tolterodine medicine.drug adult diaper medicine.medical_specialty sex difference media_common.quotation_subject Urinary system bacteriuria Bacteriuria Urination urethral catheter paraplegia Internal medicine medicine cross-sectional study follow up human Urinary Bladder Neurogenic Oxybutynin micturition Spinal Cord Injuries drug use Solifenacin business.industry questionnaire asymptomatic bacteriuria medicine.disease propiverine tolterodine major clinical study urethral catheterization spinal cord injury multicenter study Neurology (clinical) botulinum toxin A darifenacin urinary tract infection business |
| ISSN: | 0003-3723 |
| Popis: | WOS: 000337233100009 PubMed ID: 24732167 Study design: Multi-center, cross-sectional study. Objectives: Our aim was to evaluate the treatment methods and follow-up of neurogenic bladder in patients with traumatic spinal cord injury retrospectively using a questionnaire. Setting: Turkey. Methods: Three hundred and thirty-seven patients who had spinal cord injury for at least 2 years were enrolled from six centers in the neurogenic bladder study group. They were asked to fill-out a questionnaire about treatments they received and techniques they used for bladder management. Results: The study included 246 male and 91 female patients with a mean age of 42 +/- 14 years. Intermittent catheterization (IC) was performed in 77.9% of the patients, 3.8% had indwelling catheters, 13.8% had normal spontaneous micturition, 2.6% performed voiding maneuvers, 1.3% used diapers and 0.6% used condom catheters. No gender difference was found regarding the techniques used in bladder rehabilitation (P > 0.05). Overall, 63.2% of patients used anticholinergic drugs; anticholinergic drug use was similar between genders (P > 0.05). The most common anticholinergic drug used was oxybutynin (40.3%), followed by trospium (32.6%), tolterodine (19.3%) darifenacin (3.3%), propiverine (3.3%) and solifenacin (1.1%). The specialties of the physicians who first prescribed the anticholinergic drug were physiatrists (76.2%), urologists (22.1%) and neurologists (1.7%). Only four patients had previously received injections of botulinum-toxin-A into the detrusor muscle and three of them stated that their symptoms showed improvement. Most of the patients (77%) had regular follow-up examinations, including urine cultures, urinary system ultrasound and urodynamic tests, when necessary; the reasons for not having regular control visits were living distant from hospital (15.3%) and monetary problems (7.7%). Of the patients, 42.7% did not experience urinary tract infections (UTI), 36.4% had bacteriuria but no UTI episodes with fever, 15.9% had 1-2 clinical UTI episodes per year and 5% had >= 3 clinical UTIs. The clinical characteristics of patients with and without UTI (at least one symptomatic UTI during 1 year) were similar (P40.05). The frequency of symptomatic UTI was similar in patients using different bladder management techniques (P > 0.05). Conclusion: The most frequently used technique for bladder rehabilitation in patients with SCI was IC (77.9%). In all, 63.2% of patients used anticholinergic drugs, oxybutynin being the most commonly used drug. Also, 77% of patients had regular control visits for neurogenic bladder; 42.7% did not experience any UTIs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|